These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1402213)
1. Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass. D'Addato M; Curti T; Bertini D; Donini I; Ferrero R; Fiorani P; Pellegrino F; Vecchioni R; Visconti W; Zinicola N Int Angiol; 1992; 11(2):106-12. PubMed ID: 1402213 [TBL] [Abstract][Full Text] [Related]
2. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037 [TBL] [Abstract][Full Text] [Related]
3. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year]. Rohn V; Pirk J; Mach T Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387 [TBL] [Abstract][Full Text] [Related]
5. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis. Cataldo G; Heiman F; Lavezzari M; Marubini E Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928 [TBL] [Abstract][Full Text] [Related]
6. [Chronic treatment of vascular diseases with indobufen]. Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients. Monaco M; Di Tommaso L; Pinna GB; Lillo S; Schiavone V; Stassano P J Vasc Surg; 2012 Jul; 56(1):96-105. PubMed ID: 22551909 [TBL] [Abstract][Full Text] [Related]
8. [The effect of indobufen on patency in femoro-popliteal/crural bypass using artificial grafts]. Cernak I; Lotina S; Davidović L Vojnosanit Pregl; 1994; 51(3):214-9. PubMed ID: 8560834 [TBL] [Abstract][Full Text] [Related]
9. The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results. Rosenthal D; Mittenthal MJ; Ruben DM; Jones DH; Estes JW; Stanton PE; Lamis PA Am Surg; 1987 Sep; 53(9):477-81. PubMed ID: 3631756 [TBL] [Abstract][Full Text] [Related]
11. Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease. Fabris F; Steffan A; Randi ML; Avruscio GP; Cordiano I; Girolami A J Med; 1992; 23(2):81-92. PubMed ID: 1512524 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
13. Indobufen: an updated review of its use in the management of atherothrombosis. Bhana N; McClellan KJ Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445 [TBL] [Abstract][Full Text] [Related]
14. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Edmondson RA; Cohen AT; Das SK; Wagner MB; Kakkar VV Lancet; 1994 Oct; 344(8927):914-8. PubMed ID: 7934346 [TBL] [Abstract][Full Text] [Related]
15. A linear model suitable for assessing graft patency in controlled clinical trials. SINBA Group. Marubini E; Montoro C; Mezzanotte G; Petroccione A; Cataldo G; Rovelli F Control Clin Trials; 1990 Dec; 11(6):420-32. PubMed ID: 1963134 [TBL] [Abstract][Full Text] [Related]
16. Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention. Barillà F; Pulcinelli FM; Mangieri E; Torromeo C; Tanzilli G; Dominici T; Pellicano M; Paravati V; Acconcia MC; Gaudio C Platelets; 2013; 24(3):183-8. PubMed ID: 22646157 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA). Cataldo G; Braga M; Pirotta N; Lavezzari M; Rovelli F; Marubini E Circulation; 1993 Nov; 88(5 Pt 2):II93-8. PubMed ID: 8222202 [TBL] [Abstract][Full Text] [Related]
18. Patency rate of small caliber fibrous polyurethane vascular prostheses implanted in the dog carotid and femoral artery improved by use of acetylsalicylic acid and dipyridamol. Hess F; Steeghs S; Braun B; van Det R; Grande P; Jerusalem C; Skotnicki S Thorac Cardiovasc Surg; 1988 Aug; 36(4):221-6. PubMed ID: 3187983 [TBL] [Abstract][Full Text] [Related]
19. Use of aspirin associates with longer primary patency of hemodialysis grafts. Dixon BS; Beck GJ; Dember LM; Vazquez MA; Greenberg A; Delmez JA; Allon M; Himmelfarb J; Hu B; Greene T; Radeva MK; Davidson IJ; Ikizler TA; Braden GL; Lawson JH; Cotton JR; Kusek JW; Feldman HI; J Am Soc Nephrol; 2011 Apr; 22(4):773-81. PubMed ID: 21415156 [TBL] [Abstract][Full Text] [Related]
20. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass. Rychlik IJ; Davey P; Murphy J; O'Donnell ME J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]